Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
70
Price
$596.19
Total Value
$41.73K
Shares Held After
45,374
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
820
Price
$588.51
Total Value
$482.58K
Shares Held After
45,444
% of Holdings
1.8%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
2,970
Price
$587.61
Total Value
$1.75M
Shares Held After
46,264
% of Holdings
6.0%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
1,689
Price
$586.17
Total Value
$990.05K
Shares Held After
49,234
% of Holdings
3.3%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
994
Price
$585.18
Total Value
$581.67K
Shares Held After
50,923
% of Holdings
1.9%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
1,475
Price
$584.07
Total Value
$861.50K
Shares Held After
51,917
% of Holdings
2.8%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
80
Price
$582.86
Total Value
$46.63K
Shares Held After
53,392
% of Holdings
0.1%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
May 6, 2026
Sale
Shares
1,800
Price
$84.60
Total Value
$152.28K
Shares Held After
207,023
% of Holdings
0.9%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
May 6, 2026
Sale
Shares
3,700
Price
$83.92
Total Value
$310.50K
Shares Held After
208,823
% of Holdings
1.7%

MBX Biosciences, Inc. (MBX)

Azoulay Salomon — Chief Medical Officer
May 6, 2026
Sale
Shares
231
Price
$29.54
Total Value
$6.82K
Shares Held After
14,769
% of Holdings
1.5%
Shares
60,000
Price
$75.62
Total Value
$4.54M
Shares Held After
3,001,694
% of Holdings
2.0%

DAVITA INC. (DVA)

HEARTY JAMES O — Chief Compliance Officer
May 6, 2026
Sale
Shares
2,184
Price
$174.87
Total Value
$381.92K
Shares Held After
35,953
% of Holdings
5.7%
May 6, 2026
Sale
Shares
104,544
Price
$55.09
Total Value
$5.76M
Shares Held After
35,470
% of Holdings
74.7%

Vericel Corp (VCEL)

SIEGAL JONATHAN — Principal Accounting Officer
May 6, 2026
Sale
Shares
3,433
Price
$38.00
Total Value
$130.45K
Shares Held After
2,540
% of Holdings
57.5%
Shares
11,794
Price
$76.10
Total Value
$897.57K
Shares Held After
927,504
% of Holdings
1.3%
Shares
93,206
Price
$75.33
Total Value
$7.02M
Shares Held After
939,298
% of Holdings
9.0%
May 6, 2026
Sale
Shares
50,000
Price
$55.01
Total Value
$2.75M
Shares Held After
0
% of Holdings
100.0%

InspireMD, Inc. (NSPR)

Stuka Paul — Director
May 6, 2026
Purchase
Shares
1,517
Price
$1.12
Total Value
$1.70K
Shares Held After
525,221
% of Holdings
0.3%

InspireMD, Inc. (NSPR)

Ward Scott R. — Director
May 6, 2026
Purchase
Shares
15,995
Price
$1.15
Total Value
$18.39K
Shares Held After
163,841
% of Holdings
9.8%
May 6, 2026
Sale
Shares
57,365
Price
$8.06
Total Value
$462.16K
Shares Held After
5,137,559
% of Holdings
1.1%
May 6, 2026
Sale
Shares
5,000
Price
$8.00
Total Value
$40.00K
Shares Held After
5,194,924
% of Holdings
0.1%

Aclarion, Inc. (ACON)

Wesemann William — Director
May 6, 2026
Purchase
Shares
1,562
Price
$3.30
Total Value
$5.15K
Shares Held After
1,563
% of Holdings
99.9%

VERACYTE, INC. (VCYT)

McGuire Annie — SVP, General Counsel
May 6, 2026
Sale
Shares
5,102
Price
$40.00
Total Value
$204.08K
Shares Held After
143,708
% of Holdings
3.4%

VERACYTE, INC. (VCYT)

McGuire Annie — SVP, General Counsel
May 6, 2026
Sale
Shares
5,102
Price
$38.05
Total Value
$194.13K
Shares Held After
148,810
% of Holdings
3.3%
May 6, 2026
Sale
Shares
607
Price
$29.54
Total Value
$17.93K
Shares Held After
727,667
% of Holdings
0.1%
May 6, 2026
Sale
Shares
4,800
Price
$32.44
Total Value
$155.69K
Shares Held After
93,640
% of Holdings
4.9%
May 6, 2026
Sale
Shares
4,800
Price
$30.07
Total Value
$144.35K
Shares Held After
98,440
% of Holdings
4.6%

ELI LILLY & Co (LLY)

LILLY ENDOWMENT INC — Former 10% Shareholder
May 6, 2026
Sale
Shares
2,208
Price
$996.18
Total Value
$2.20M
Shares Held After
91,881,150
% of Holdings
0.0%

ELI LILLY & Co (LLY)

LILLY ENDOWMENT INC — Former 10% Shareholder
May 6, 2026
Sale
Shares
13,620
Price
$995.23
Total Value
$13.55M
Shares Held After
91,883,358
% of Holdings
0.0%
May 6, 2026
Sale
Shares
10,136
Price
$8.04
Total Value
$81.49K
Shares Held After
2,565,226
% of Holdings
0.4%
May 6, 2026
Sale
Shares
1,406
Price
$58.13
Total Value
$81.72K
Shares Held After
60,680
% of Holdings
2.3%
May 6, 2026
Sale
Shares
5,634
Price
$57.18
Total Value
$322.13K
Shares Held After
62,086
% of Holdings
8.3%
May 6, 2026
Purchase
Shares
3,792
Price
$12.23
Total Value
$46.37K
Shares Held After
379,738
% of Holdings
1.0%
May 6, 2026
Purchase
Shares
38,154
Price
$12.23
Total Value
$466.55K
Shares Held After
3,821,285
% of Holdings
1.0%

ILLUMINA, INC. (ILMN)

Wedel Christensen Jakob — SVP, Strategy/Corp Development
May 6, 2026
Sale
Shares
700
Price
$139.04
Total Value
$97.33K
Shares Held After
15,056
% of Holdings
4.4%

Liquidia Corp (LQDA)

JEFFS ROGER — Director
May 6, 2026
Sale
Shares
25,000
Price
$40.78
Total Value
$1.02M
Shares Held After
1,373,095
% of Holdings
1.8%
May 6, 2026
Sale
Shares
14,635
Price
$0.66
Total Value
$9.66K
Shares Held After
1,657,835
% of Holdings
0.9%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Weiss Amir — Chief Accounting Officer
May 6, 2026
Sale
Shares
10,679
Price
$36.00
Total Value
$384.44K
Shares Held After
20,016
% of Holdings
34.8%
May 6, 2026
Purchase
Shares
80,805
Price
$61.88
Total Value
$5.00M
Shares Held After
151,207
% of Holdings
53.4%
May 6, 2026
Purchase
Shares
1,000
Price
$61.69
Total Value
$61.69K
Shares Held After
15,330
% of Holdings
6.5%

MERIT MEDICAL SYSTEMS INC (MMSI)

Parra Raul Jr. — CFO AND TREASURER
May 6, 2026
Purchase
Shares
1,500
Price
$61.01
Total Value
$91.52K
Shares Held After
58,843
% of Holdings
2.5%
May 6, 2026
Purchase
Shares
2,000
Price
$60.44
Total Value
$120.88K
Shares Held After
49,792
% of Holdings
4.0%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 6, 2026
Sale
Shares
100
Price
$156.00
Total Value
$15.60K
Shares Held After
666
% of Holdings
13.1%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 6, 2026
Sale
Shares
100
Price
$155.97
Total Value
$15.60K
Shares Held After
766
% of Holdings
11.5%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 6, 2026
Sale
Shares
240
Price
$154.41
Total Value
$37.06K
Shares Held After
866
% of Holdings
21.7%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 6, 2026
Sale
Shares
128
Price
$153.42
Total Value
$19.64K
Shares Held After
1,106
% of Holdings
10.4%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 6, 2026
Sale
Shares
424
Price
$152.67
Total Value
$64.73K
Shares Held After
1,234
% of Holdings
25.6%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 6, 2026
Sale
Shares
8
Price
$151.57
Total Value
$1.21K
Shares Held After
1,658
% of Holdings
0.5%
May 6, 2026
Sale
Shares
3,167
Price
$22.88
Total Value
$72.46K
Shares Held After
3,166
% of Holdings
50.0%

Avalo Therapeutics, Inc. (AVTX)

Sullivan Christopher Ryan — Chief Financial Officer
May 6, 2026
Sale
Shares
8,900
Price
$22.57
Total Value
$200.91K
Shares Held After
423
% of Holdings
95.5%
Version: v26.5.2